Chan Zuckerberg Biohub commits 500 million dollars to AI cell models

Chan Zuckerberg Biohub is investing $500 million within a period of five years in developing artificial intelligence models of human cells.

These tools can be used to investigate diseases digitally at unprecedented speeds beyond what laboratory studies can offer.

The non-profit organisation, founded in 2016 by Meta Chief Executive Officer Mark Zuckerberg and Dr Priscilla Chan, revealed the funding programme last week as part of the launch of a plan to freely distribute all data created by the technology to researchers worldwide.

The organisation will allocate $400 million for its own initiatives, while another $100 million will be offered as grants to other researchers.

Nvidia has been listed as one of the collaborators for the project. Biohub's Head of Science, Alex Rives, said the challenge ahead is fundamentally one of data scale.

"To build artificial intelligence that can accurately represent the full complexity of biology, we need orders of magnitude more data than exists today," he said at the announcement.

Despite being the holder of the world’s largest single-cell datasets, the organisation admits that such massive investments must be made on a worldwide scale.

If the model were sufficiently accurate, it would work as a digital laboratory where scientists could predict how the cell reacts to various stimuli, diseases, or drugs without performing real-life experiments.

Biohub suggests that this would help uncover the underlying mechanisms of unknown diseases. This initiative builds on the founders' long-term commitment to curing or managing all diseases by the end of the century through aggressive technological innovation.